Astellas Pharma Global Development Inc

学者数16

论文数5

被引数0

关联论文 (5)

发表时间

Discussion of “LAMBDA: Large Model Based Data Agent”关于“LAMBDA：基于大型模型的数据智能体”的讨论

Journal of the American Statistical Association

IF3

2026-04-14

PREAI

Xuewei Wang; Rui (Sammi) Tang

First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial 一线zolbetuximab联合mFOLFOX6和nivolumab治疗不可切除的CLDN18.2阳性胃或胃食管结合部腺癌：一项Ⅱ期临床试验

Nature Medicine

IF50

2026-03-16

OAAI

Kohei Shitara; Hirokazu Shoji; Nicola Fazio; Sara Lonardi; Keun-Wook Lee; Li-Yuan Bai; Kensei Yamaguchi; Jean-Philippe Metges; Gianluca Masi; Denis Smith; Tae-Yong Kim; Maria Matsangou; Archita Shrivastava; Miaomai Zhou; Jason Hill; Abraham Guerrero; Xuewei Wang; Aziz Zaanan; Samuel J. Klempner

Efficacy and Safety of Mirabegron in Patients with Overactive Bladder and Cardiovascular Comorbidities: A Post Hoc Analysis of Randomised Trials Mirabegron在伴有心血管合并症的过度活跃膀胱患者中的疗效与安全性：一项随机试验的回顾性分析

European Urology Focus

IF5.6

2026-02-18

OAAI

Amy Lockefeer; Arianne Schild; Swapneel Anaokar; Mikkel Fode

Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies

ESMO Open

IF8.3

2026-01-08

OAAI

K. Shitara; E. Smyth; F. Lordick; R. Pophale; C. Matney; M. Matsangou; G. Gourgioti; M. Oh; R. Ranganath; S.J. Klempner

Analytical and Clinical Performance of the VENTANA CLDN18 (43-14A) RxDx Assay in Gastric and Gastroesophageal Junction Adenocarcinoma Tissue Samples in SPOTLIGHT and GLOW VENTANA CLDN18 (43-14A) RxDx检测在SPOTLIGHT和GLOW研究中对胃及胃食管结合部腺癌组织样本的分析性能和临床性能

Modern Pathology

IF5.5

2025-07-16

OAAI

Steven P. Stratton; Lizhen Pang; Judith Pugh; Margarita Kouzova; Drew Baldwin; Jannine McDonald; Rebecka Lawrence-Glaze; Sean Moran; Abraham Guerrero; Diarmuid Moran